Date published: 2025-12-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

4-Phenoxyphenyl isocyanate (CAS 59377-19-4)

0.0(0)
Write a reviewAsk a question

CAS Number:
59377-19-4
Molecular Weight:
211.22
Molecular Formula:
C13H9NO2
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

4-Phenoxyphenyl isocyanate is a chemical compound in biochemistry. It is a versatile reagent that is in the synthesis of various organic compounds. 4-Phenoxyphenyl Isocyanate is for its ability to react with a wide range of nucleophiles, making it useful in the field of organic synthesis. 4-Phenoxyphenyl isocyanate is particularly useful in the preparation of carbamates, ureas, and other nitrogen-containing compounds. Its reactivity and selectivity make it an important building block in the development of new agrochemicals. 4-Phenoxyphenyl isocyanate may act to exhibit interesting biological activities, making it a subject of interest in the study of structure-activity relationships. 4-Phenoxyphenyl isocyanate plays a role in the advancement of biochemistry and organic chemistry.


4-Phenoxyphenyl isocyanate (CAS 59377-19-4) References

  1. Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonists.  |  Fotsch, C., et al. 2001. J Med Chem. 44: 2344-56. PMID: 11428928
  2. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure-activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.  |  Matsuno, K., et al. 2003. Bioorg Med Chem Lett. 13: 3001-4. PMID: 12941321
  3. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.  |  Matsuno, K., et al. 2003. J Med Chem. 46: 4910-25. PMID: 14584942
  4. Novel glycine transporter type-2 reuptake inhibitors. Part 1: alpha-amino acid derivatives.  |  Wolin, RL., et al. 2004. Bioorg Med Chem. 12: 4477-92. PMID: 15265498
  5. Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives.  |  Wolin, RL., et al. 2004. Bioorg Med Chem. 12: 4493-509. PMID: 15265499
  6. Novel potent and efficacious nonpeptidic urotensin II receptor agonists.  |  Lehmann, F., et al. 2006. J Med Chem. 49: 2232-40. PMID: 16570919
  7. Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists.  |  Kym, PR., et al. 2006. J Med Chem. 49: 2339-52. PMID: 16570930
  8. Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides.  |  Raffa, D., et al. 2009. Eur J Med Chem. 44: 165-78. PMID: 18485541
  9. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts.  |  Gieling, RG., et al. 2012. J Med Chem. 55: 5591-600. PMID: 22621623
  10. Screening of efficient siRNA carriers in a library of surface-engineered dendrimers.  |  Liu, H., et al. 2016. Sci Rep. 6: 25069. PMID: 27121799
  11. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.  |  Bozdag, M., et al. 2018. J Med Chem. 61: 6328-6338. PMID: 29962205

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

4-Phenoxyphenyl isocyanate, 1 g

sc-232952
1 g
$51.00